ATE319744T1 - Antikörper zur stimulierung der produktion von il-1ra - Google Patents

Antikörper zur stimulierung der produktion von il-1ra

Info

Publication number
ATE319744T1
ATE319744T1 AT02793224T AT02793224T ATE319744T1 AT E319744 T1 ATE319744 T1 AT E319744T1 AT 02793224 T AT02793224 T AT 02793224T AT 02793224 T AT02793224 T AT 02793224T AT E319744 T1 ATE319744 T1 AT E319744T1
Authority
AT
Austria
Prior art keywords
antibodies
production
stimulate
monocytes
macrophages
Prior art date
Application number
AT02793224T
Other languages
English (en)
Inventor
Dominique Bourel
Martine Bruley-Rosset
Frederic Dhainaut
Jacky Lirochon
Original Assignee
Lab Francais Du Fractionnement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab Francais Du Fractionnement filed Critical Lab Francais Du Fractionnement
Application granted granted Critical
Publication of ATE319744T1 publication Critical patent/ATE319744T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT02793224T 2001-11-09 2002-11-08 Antikörper zur stimulierung der produktion von il-1ra ATE319744T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0114518A FR2832155B1 (fr) 2001-11-09 2001-11-09 Anticorps stimulant la production d'il-1ra

Publications (1)

Publication Number Publication Date
ATE319744T1 true ATE319744T1 (de) 2006-03-15

Family

ID=8869239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793224T ATE319744T1 (de) 2001-11-09 2002-11-08 Antikörper zur stimulierung der produktion von il-1ra

Country Status (14)

Country Link
US (1) US20050089520A1 (de)
EP (1) EP1438341B1 (de)
JP (1) JP4477874B2 (de)
AT (1) ATE319744T1 (de)
AU (1) AU2002358885B2 (de)
CA (1) CA2467853A1 (de)
CY (1) CY1105017T1 (de)
DE (1) DE60209797T2 (de)
DK (1) DK1438341T3 (de)
ES (1) ES2256579T3 (de)
FR (1) FR2832155B1 (de)
IL (2) IL161872A0 (de)
PT (1) PT1438341E (de)
WO (1) WO2003040188A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180005856A (ko) * 2016-07-07 2018-01-17 동국대학교 산학협력단 IL-1ra를 포함하는 피부 자극 물질 스크리닝용 조성물 및 이를 이용한 피부 자극 물질의 스크리닝 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19920704C1 (de) * 1999-01-26 2000-08-31 Technologie Integrale Ltd Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
FR2794460A1 (fr) * 1999-06-07 2000-12-08 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'igg humaines possedant une activite immunomodulatrice
FR2794461B1 (fr) * 1999-06-07 2004-01-23 Lab Francais Du Fractionnement Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice

Also Published As

Publication number Publication date
EP1438341B1 (de) 2006-03-08
US20050089520A1 (en) 2005-04-28
FR2832155B1 (fr) 2004-07-09
CA2467853A1 (fr) 2003-05-15
JP4477874B2 (ja) 2010-06-09
FR2832155A1 (fr) 2003-05-16
WO2003040188A1 (fr) 2003-05-15
DK1438341T3 (da) 2006-06-06
IL161872A (en) 2009-12-24
JP2005519027A (ja) 2005-06-30
AU2002358885B2 (en) 2009-01-08
CY1105017T1 (el) 2009-11-04
PT1438341E (pt) 2006-06-30
EP1438341A1 (de) 2004-07-21
DE60209797D1 (de) 2006-05-04
ES2256579T3 (es) 2006-07-16
DE60209797T2 (de) 2007-01-11
IL161872A0 (en) 2005-11-20

Similar Documents

Publication Publication Date Title
HUP0402162A2 (hu) A humán angiopoietin-2 specifikus kötőanyagai
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
TR200002731T2 (tr) Proteolitik antikorların indüktör ve inhibitörlerinin tanımlanması, kompozisyonları ve kullanımları için metotlar
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
CR7875A (es) Variantes de inmunoglobina y usos de esto
ATE475673T1 (de) Anti-il-22ra antikörper und bindungspartner und verwendungsmethoden bei entzündung
ATE439166T1 (de) Hemmung von il-17 produktion
IL172854A0 (en) Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations
ATE363531T1 (de) Claudin polypeptide
DK1259593T3 (da) Tand-progenitorcelle og fremgangsmåde til frembringelse heraf
DK2335720T3 (da) Autolog T-cellevacciner mod multiple sclerose
ATE416756T1 (de) Methoden zur verwendung von lamellaren körpern für therapeutische zwecke
TR200402030T4 (tr) İkame edilen I-aminobutan-3-ol-türevleri
ATE319744T1 (de) Antikörper zur stimulierung der produktion von il-1ra
HUP0400458A2 (hu) Kobalaminkötő fehérjéket expresszáló transzgenikus növények
HUP0300997A2 (hu) A MIA-fehérje alkalmazása immunterápiában
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
GB0119015D0 (en) A fusion protein
AU2003259750A8 (en) Methods and compositions for targeting secretory lysosomes
DE60336746D1 (de) Trimer-proteine zur trimer-zytokine
DE60128374D1 (de) Varianten des hauptallergen par j 2 von parietaria judaica
MY142798A (en) Methods for preventing glyconoylation of proteins
ATE295746T1 (de) Radioaktiv beschichtete stents
TW200635951A (en) Specific binding agents of human angiopoietin-2
FR2839721B1 (fr) Antigene polypeptidique induisant des anticorps neutralisant le vih

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1438341

Country of ref document: EP

EEIH Change in the person of patent owner